{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:07:28Z","timestamp":1793394448424,"version":"4.5.0"},"reference-count":22,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background<\/jats:bold>\n                    : Postoperative nausea and vomiting (PONV) is a usual complication in patients undergoing laparoscopic cholecystectomy. Minimized opioid use due to surgery has been shown to have a better effect on patient recovery after surgery. In this study we evaluate the effect of opioid free anesthesia for postoperative nausea and vomiting in laparoscopic cholecystectomy.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Materials and methods<\/jats:bold>\n                    : 80 patients aged 20-65 years old were included in this randomized, clinical and prospective trial. The patients belonged to the ASA classifications 1 and 2 and were scheduled for laparoscopic cholecystectomy. Patients were classified into two groups: group 1 (fentanyl group- FG), which included 40 patients who received opioid anesthesia, and group 2 (opioid free anesthesia group-OFAG) which included 40 patients who received opioid free anesthesia. In patients from group 1 (fentanyl group -FG) introduction to general anesthesia consisted of giving midazolam at 0.04 mg\/kg, fentanyl at 0.002 mg\/kg, 2 mg\/kg of propofol and 0.6 mg\/kg of rocuronium bromide. These patients received fractionated bolus doses of fentanyl during surgery. Prior to general anesthesia these patients did not receive dexamethasone. The patients from group 2 (opioid free anesthesia group - OFAG) received dexamethasone at 0.1 mg\/kg and 1 g of paracetamol before introduction to anesthesia as a pre-emptive analgesia. Introduction to anesthesia consisted of giving midazolam at 0.04 mg\/kg, lidocaine at 1 mg\/kg, propofol at 2 mg\/kg, ketamine at 0.5 mg\/kg, and 0.6 mg\/kg of rocuronium bromide. Immediately after intubation, continuous intravenous infusion with lidocaine at 2 mg\/kg\/h and magnesium sulfate at 1.5 g\/h was given. In this group, fentanyl was not given either during the introduction of anesthesia or during the intraoperative period. Immediately after extraction of the gallbladder patients from group 2 (OFAG) received 2.5 g of metamizole intravenously. PONV were recorded in the postoperative period of 24 hours after surgery.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    : There was no significant difference with respect to age, weight, sex, duration of surgery, and anesthesia time. PONV at different time intervals were statistically not significant at all postoperative time points \u2013 1 hr, 4 hr, 8 hr, 12 hr and 24 hr after surgery in fentanyl group compared to opioid free anesthesia group. Even not statistically significant, PONV have occurred more often in patients who received opioid anesthesia.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion<\/jats:bold>\n                    : Postoperative nausea and vomiting occurs more often in patients who received opioids during laparoscopic cholecystectomy compared to patients who received opioid free anesthesia, but without statistical significance.\n                  <\/jats:p>","DOI":"10.2478\/prilozi-2022-0042","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T16:31:25Z","timestamp":1670344285000},"page":"101-108","source":"Crossref","is-referenced-by-count":19,"title":["Postoperative Nausea and Vomiting in Opioid-Free Anesthesia Versus Opioid Based Anesthesia in Laparoscopic Cholecystectomy"],"prefix":"10.2478","volume":"43","author":[{"given":"Marija","family":"Toleska","sequence":"first","affiliation":[{"name":"University Clinical Center \u201cMother Teresa\u201d Skopje, University Clinic of TOARILUC , Department of Anesthesiology, Reanimation and Intensive Care \u2013 KARIL, Medical Faculty - Skopje, University \u2033Ss. Cyril and Methodius\u2033 Skopje , Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Dimitrovski","sequence":"additional","affiliation":[{"name":"University Clinical Center \u201cMother Teresa\u201d Skopje, University Clinic of TOARILUC , Department of Anesthesiology, Reanimation and Intensive Care \u2013 KARIL, Medical Faculty - Skopje, University \u2033Ss. Cyril and Methodius\u2033 Skopje , Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha Toleska","family":"Dimitrovska","sequence":"additional","affiliation":[{"name":"University Clinical Center \u201cMother Teresa\u201d Skopje, University Clinic for Thoracic and Vascular Surgery , Medical Faculty -Skopje, University \u2033Ss. Cyril and Methodius\u2033 Skopje , Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2022,12,4]]},"reference":[{"key":"2026071212092369446_j_prilozi-2022-0042_ref_001","doi-asserted-by":"crossref","unstructured":"1. Gan TJ. Mechanisms underlying postoperative nausea and vomiting and neurotransmitter receptor antagonist-based pharmacotherapy. CNS Drugs 2007; 21(10): 813\u201333.10.2165\/00023210-200721100-0000317850171","DOI":"10.2165\/00023210-200721100-00003"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_002","doi-asserted-by":"crossref","unstructured":"2. Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91(3): 693\u2013700.10.1097\/00000542-199909000-0002210485781","DOI":"10.1097\/00000542-199909000-00022"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_003","unstructured":"3. Turgut HC, Arslan M. An overview of treatment options for postoperative nausea and vomiting after laparoscopic surgical procedures. Anaesth Pain & Intensive Care 2016; 20(2): 193\u2013200."},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_004","doi-asserted-by":"crossref","unstructured":"4. Kehlet H, Dahl JB. The value of \u201cmultimodal\u201d or \u201cbalanced analgesia\u201d in postoperative pain treatment. Anesth Analg. 1993; 77: 1048\u20131056.10.1213\/00000539-199311000-000308105724","DOI":"10.1213\/00000539-199311000-00030"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_005","doi-asserted-by":"crossref","unstructured":"5. Buvanendran A, Kroin JS. Multimodal analgesia for controlling acute postoperative pain. Curr Opin Anaesthesiol. 2009; 22: 588\u2013593.10.1097\/ACO.0b013e328330373a19606021","DOI":"10.1097\/ACO.0b013e328330373a"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_006","unstructured":"6. Sultana A. Opioid free anesthesia and analgesia in the bariatric patient. Anesthesiology. 2015; 123(2): 357\u2013367."},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_007","doi-asserted-by":"crossref","unstructured":"7. Naguib M, el Bakry AK, Khoshim MH, Channa AB, el Gammal M, el Gammal K, et al. Prophylactic antiemetic therapy with ondansetron, tropisetron, ganisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo. Can J Anaesth. 1996; 43(3): 226\u201331.10.1007\/BF030117398829860","DOI":"10.1007\/BF03011739"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_008","doi-asserted-by":"crossref","unstructured":"8. Arslan M, \u00c7i\u00e7ek R, Kalender H\u00dc, Yilmaz H. Preventing postoperative nausea and vomiting after laparoscopic cholecystectomy: A prospective, randomized, double-blind study. Current Therapeutic Research 2011; 72(1): 1\u201312.10.1016\/j.curtheres.2011.02.002395524924648571","DOI":"10.1016\/j.curtheres.2011.02.002"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_009","doi-asserted-by":"crossref","unstructured":"9. Bauer KP, Dom PM, Ramirez AM, O\u2019Flaherty JE. Preoperative intravenous midazolam: benefits beyond anxiolysis. J Clin Anesth 2004; 16: 177\u201383.10.1016\/j.jclinane.2003.07.00315217656","DOI":"10.1016\/j.jclinane.2003.07.003"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_010","unstructured":"10. Heidari SM, Saryazdi H, Saghaei M. Effect of intravenous midazolam premedication on postoperative nausea and vomiting after cholecystectomy. Acta Anaesthesiol Taiwan 2004; 42: 77\u201380."},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_011","unstructured":"11. Wilson S, Meyer H, Fecho K. Postoperative nausea and vomiting after inpatient and outpatient breast surgery: incidence and effects of midazolam. Ambulatory Surgery 2009; 15(4): 68-72."},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_012","doi-asserted-by":"crossref","unstructured":"12. Jung JS, Park JS, Kim SO, Lim DG, Park SS, Kwak KH, et al. Prophylactic antiemetic effect of midazolam after middle ear surgery. Otolaryngol Head Neck Surg. 2007; 137: 753\u20136.10.1016\/j.otohns.2007.07.02417967640","DOI":"10.1016\/j.otohns.2007.07.024"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_013","doi-asserted-by":"crossref","unstructured":"13. Ali MY, Uddin R, Islam A, Kamal M, Islam SMR, Rahman AKMS. Post operative nausea and vomiting after laparoscopic cholecystectomy: comparison of prophylactic effect of dexamethasone with ondansetron. JBSA 2011; 24(2): 60\u201364.","DOI":"10.3329\/jbsa.v24i2.19803"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_014","doi-asserted-by":"crossref","unstructured":"14. Shirakami G, Teratani Y, Segawa H, Matsuura S, Shichino T, Fukuda K. Omission of fentanyl during sevoflurane anesthesia decreases the incidences of postoperative nausea and vomiting and accelerates postanesthesia recovery in major breast cancer surgery. J Anesth. 2006; 20: 188\u2013195.10.1007\/s00540-006-0413-x16897238","DOI":"10.1007\/s00540-006-0413-x"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_015","doi-asserted-by":"crossref","unstructured":"15. Ziemann-Gimmel P, Goldfarb AA, Koppman J, Marema RT. Opioid-free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis. Br J Anaesth 2014; 112(5): 906\u201311.10.1093\/bja\/aet55124554545","DOI":"10.1093\/bja\/aet551"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_016","doi-asserted-by":"crossref","unstructured":"16. \u04e6brink E, Jildenst\u00e5l P, Oddby E, Jakobsson JG. Post-operative nausea and vomiting: Update on predicting the probability and ways to minimize its occurrence, with focus on ambulatory surgery. International Journal of Surgery 2015; 15: 100\u2013106.10.1016\/j.ijsu.2015.01.02425638733","DOI":"10.1016\/j.ijsu.2015.01.024"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_017","unstructured":"17. Naguib K, Osman HA, Al-Khayat HC, Zikri AM. Prevention of post-operative nausea and vomiting following laparoscopic surgery-ephedrine vs propofol. Middle East J Anesthesiol 1998; 14: 219\u2013230."},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_018","doi-asserted-by":"crossref","unstructured":"18. Apfel CC, Meyer A, Orhan-Sungur M, Jalota L, Whelan RP, Jukar-Rao S. Supplemental intravenous crystalloid for the prevention of postoperative nausea and vomiting: quantitative review. Br J Anaesth 2012; 108: 893\u2013902.10.1093\/bja\/aes13822593126","DOI":"10.1093\/bja\/aes138"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_019","doi-asserted-by":"crossref","unstructured":"19. Rao V, Bala I, Jain D, Bharti N. Effect of intravenous dextrose administration on postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A randomised controlled trial. Eur J Anaesthesiol 2017; 34(10): 705\u2013707.10.1097\/EJA.000000000000064328872580","DOI":"10.1097\/EJA.0000000000000643"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_020","doi-asserted-by":"crossref","unstructured":"20. Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350(24): 2441\u201351.10.1056\/NEJMoa032196130753315190136","DOI":"10.1056\/NEJMoa032196"},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_021","unstructured":"21. Feinleib J, Kwan LH, Yamani A, Davidson A. Postoperative nausea and vomiting. Up to Date, Inc, 2018. https:\/\/www.uptodate.com."},{"key":"2026071212092369446_j_prilozi-2022-0042_ref_022","doi-asserted-by":"crossref","unstructured":"22. Chan MT, Choi KC, Gin T, Chui PT, Short TG, Yuen PM, et al. The additive interactions between ondansetron and droperidol for preventing postoperative nausea and vomiting. Anesth Analg 2006; 103(5): 1155\u201362.10.1213\/01.ane.0000239223.74552.0a17056948","DOI":"10.1213\/01.ane.0000239223.74552.0a"}],"container-title":["PRILOZI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/prilozi-2022-0042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:58:48Z","timestamp":1783900728000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/prilozi-2022-0042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,12,4]]},"published-print":{"date-parts":[[2022,11,1]]}},"alternative-id":["10.2478\/prilozi-2022-0042"],"URL":"https:\/\/doi.org\/10.2478\/prilozi-2022-0042","relation":{},"ISSN":["1857-8985"],"issn-type":[{"value":"1857-8985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]}}}